SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications worldwide. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone770-419-7525
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.85 million
Profitability
Miscellaneous
Employees14
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable
SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions
What is SANUWAVE Health's stock symbol?
SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."
How were SANUWAVE Health's earnings last quarter?
SANUWAVE Health, Inc. (OTCMKTS:SNWV) posted its quarterly earnings results on Friday, November, 15th. The company reported ($0.01) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.02) by $0.01. The company had revenue of $0.20 million for the quarter, compared to the consensus estimate of $0.40 million. View SANUWAVE Health's Earnings History.
When is SANUWAVE Health's next earnings date?
Has SANUWAVE Health been receiving favorable news coverage?
Media headlines about SNWV stock have been trending positive recently, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. SANUWAVE Health earned a media sentiment score of 3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for SANUWAVE Health.
Who are some of SANUWAVE Health's key competitors?
Some companies that are related to SANUWAVE Health include iCAD (ICAD), Venus Concept (VERO), TELA Bio (TELA), Cytosorbents (CTSO), Spectral Medical (EDTXF), BRAINSWAY LTD/S (BWAY), Liquidia Technologies (LQDA), BeyondAirInc . (XAIR), Neuronetics (STIM), Nephros (NEPH), STRATA Skin Sciences (SSKN), Nephros (NEPHD), AIT Therapeutics (AITB), Sensus Healthcare (SRTS) and Pro-Dex (PDEX).
What other stocks do shareholders of SANUWAVE Health own?
Who are SANUWAVE Health's key executives?
SANUWAVE Health's management team includes the folowing people:
- Mr. Kevin A. Richardson II, Chairman & CEO (Age 51)
- Mr. Shri P. Parikh, Pres (Age 47)
- Ms. Lisa E. Sundstrom, Chief Financial Officer (Age 50)
- Mr. Peter Stegagno, Chief Operating Officer (Age 59)
- Dr. Iulian Cioanta, Chief Science & Technology Officer (Age 56)
How do I buy shares of SANUWAVE Health?
Shares of SNWV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is SANUWAVE Health's stock price today?
One share of SNWV stock can currently be purchased for approximately $0.16.
How big of a company is SANUWAVE Health?
SANUWAVE Health has a market capitalization of $45.83 million and generates $1.85 million in revenue each year. The company earns $-11,630,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. SANUWAVE Health employs 14 workers across the globe.View Additional Information About SANUWAVE Health.
What is SANUWAVE Health's official website?
How can I contact SANUWAVE Health?
SANUWAVE Health's mailing address is 3360 Martin Farm Road Suite 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]
MarketBeat Community Rating for SANUWAVE Health (OTCMKTS SNWV)
MarketBeat's community ratings are surveys of what our community members think about SANUWAVE Health and other stocks. Vote "Outperform" if you believe SNWV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNWV will underperform the S&P 500 over the long term. You may vote once every thirty days.
